Drug Trial Radar · NCT04085367
Multicenter Study to Assess the Efficacy and Safety of Methyl Aminolevulinate Hydrochloride (MAL) 16.8% Cream (CD06809-41) Versus Vehicle Cream for Actinic Keratosis of the Face
Last checked: Nov 20, 2026Latest source record: Apr 1, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
557
Actual
Start
Sep 30, 2019
Primary completion
Mar 3, 2021
Study completion Apr 7, 2021
Sponsor
- Lead sponsor
- Galderma R&DIndustry
- Sponsor type
- Industry
- First posted
- Sep 11, 2019
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Randomized, Double-Blind, Vehicle-Controlled, Multicenter Study to Assess the Efficacy and Safety of Methyl aminolevulinate hydrochloride (MAL) 16.8% cream (CD06809-41) versus vehicle cream in the treatment of thin and moderately thick, non-hyperkeratotic, non-pigmented actinic keratosis of the face and scalp when using daylight photodynamic therapy (DL-PDT).
Conditions
- Actinic Keratoses
Interventions
MAL 16.8% creamDrug
Day light photodynamic therapy with MAL 16.8% cream
MAL Vehicle CreamDrug
Day light photodynamic therapy with MAL vehicle cream
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With Complete Response at Week 12Time frame: Week 12
Locations
60 sites in 2 countries. Site status is shown where the registry gives one.
Galderma Investigational Site (Site 8768)
Tucson, Arizona
Galderma Investigational Site (Site 8447)
Fort Smith, Arkansas
Galderma Investigational Site (Site 8577)
Encinitas, California
Galderma Investigational Site (Site 8636)
Fountain Valley, California
Galderma Investigational Site (Site 8224)
Fremont, California
Galderma Investigational Site (Site 8114)
Fresno, California
Galderma Investigational Site (Site 8758)
San Diego, California
Galderma Investigational Site (Site 8608)
Santa Monica, California
Galderma Investigational Site (Site 8778)
Denver, Colorado
Galderma Investigational Site (Site 8440)
Greenwood Village, Colorado
Galderma Investigational Site (Site 8479)
Bradenton, Florida
Galderma Investigational Site (Site 8770)
Lehigh Acres, Florida
Galderma Investigational Site (Site 8656)
Miami, Florida
Galderma Investigational Site (Site 8765)
North Miami Beach, Florida
Galderma Investigation Site (Site 8769)
Palm Springs, Florida
Galderma Investigational Site (Site 8734)
Pembroke Pines, Florida
Galderma Investigational Site (Site 8529)
Sanford, Florida
Galderma Investigational Site (Site 8126)
West Palm Beach, Florida
Galderma Investigational Site (Site 8683)
Atlanta, Georgia
Galderma Investigational Site (Site 8860)
Atlanta, Georgia
Galderma Investigational Site (Site 8667)
Columbus, Georgia
Galderma Investigational Site (Site 8755)
Boise, Idaho
Galderma Investigational Site (Site 8838)
Darien, Illinois
Galderma Investigational Site (Site 8724)
Louisville, Kentucky
Galderma Investigational Site (Site 8208)
Beverly, Massachusetts
Galderma Investigational Site (Site 8574)
Clarkston, Michigan
Galderma Investigation Site (Site 8757)
Saint Joseph, Michigan
Galderma Investigational Site (Site 8762)
Edina, Minnesota
Galderma Investigational Site (Site 8140)
New Brighton, Minnesota
Galderma Investigational Site (Site 8219)
St Louis, Missouri
Galderma Investigational Site (Site 8869)
St Louis, Missouri
Galderma Investigational Site (Site 8048)
Omaha, Nebraska
Galderma Investigational Site (Site 8420)
Portsmouth, New Hampshire
Galderma Investigational Site (Site 8759)
Albuquerque, New Mexico
Galderma Investigational Site (Site 8242)
Brooklyn, New York
Galderma Investigational Site (Site 8733)
New York, New York
Galderma Investigational Site (Site 8279)
New York, New York
Galderma Investigational Site (Site 8566)
Charlotte, North Carolina
Galderma Investigational Site (Site 8726)
Wilmington, North Carolina
Galderma Investigational Site (Site 8595)
Dublin, Ohio
Showing 40 of 60 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.